eHealth Inc. Proxy Statement Filed

Ticker: EHTH · Form: DEFA14A · Filed: May 23, 2024 · CIK: 1333493

Ehealth, Inc. DEFA14A Filing Summary
FieldDetail
CompanyEhealth, Inc. (EHTH)
Form TypeDEFA14A
Filed DateMay 23, 2024
Risk Levellow
Pages6
Reading Time7 min
Key Dollar Amounts$76 million, $37 million, $156 million
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, shareholder-voting

Related Tickers: EHTH

TL;DR

eHealth proxy filed - shareholders vote soon on directors & company stuff.

AI Summary

eHealth, Inc. filed a Definitive Additional Materials proxy statement on May 23, 2024, related to its annual meeting. The filing concerns the solicitation of proxies for the meeting, which will include the election of directors and other corporate matters. Specific details regarding the agenda items or proposals are not fully elaborated in this initial header information.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the annual meeting, allowing them to understand and vote on key company decisions, including the election of directors.

Risk Assessment

Risk Level: low — This is a standard proxy filing for an annual meeting, not indicating any unusual or high-risk events.

Key Players & Entities

  • eHealth, Inc. (company) — Registrant
  • 0001333493-24-000082 (filing_id) — Accession Number
  • May 23, 2024 (date) — Filing Date

FAQ

What type of SEC filing is this?

This is a DEFA14A filing, specifically a Definitive Additional Materials proxy statement.

Who is the filing company?

The filing company is eHealth, Inc.

When was this filing made?

The filing was made on May 23, 2024.

What is the purpose of a DEFA14A filing?

A DEFA14A filing is used to solicit proxies from shareholders for an annual or special meeting of the company.

What is the business address of eHealth, Inc.?

The business address is 13620 Ranch Road 620 N, Suite A250, Austin, TX 78717.

Filing Stats: 1,682 words · 7 min read · ~6 pages · Grade level 15 · Accepted 2024-05-23 08:39:12

Key Financial Figures

  • $76 million — re. During 2022 and 2023, we achieved a $76 million cumulative improvement to our net incom
  • $37 million — improvement to our net income (loss), a $37 million cumulative improvement to our adjusted
  • $156 million — mprovement to our adjusted EBITDA and a $156 million cumulative improvement to our operating

Filing Documents

Forward-Looking Statements

Forward-Looking Statements This letter to our stockholders from our Chief Executive Officer contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding our expectations regarding our business, operations and strategy the impact of our business transformation plan on our business and our future cost reduction efforts the effect of our marketing and branding efforts on our business our financial prospects and outlook future stockholder value expected growth and value creation the expected impact of a new equity plan on our ability to hire and retain our workforce our expected equity burn rate in 2024 cost reductions and efficiencies priorities and performance and other statements regarding our future operations, financial condition, prospects and business strategies. These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks and uncertainties described in our most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and available on the Investor Relations page of our website at httpsir.ehealthinsurance.com and on the Securities and Exchange Commission's website at www.sec.gov. In particular, we are required by Accounting Standards Codification 606 — Revenue from Contracts with Customers to make numerous assumptions that are based on historical trends and our management's judgment. These assumptions may change over time and have a material impact on our revenue recognition, guidance, and results of operations. Please review the assumptions stated in this communication carefully. All forward-looking statements in this letter are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provid

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.